Literature DB >> 30098391

An examination of protein binding and protein-facilitated uptake relating to in vitro-in vivo extrapolation.

C M Bowman1, L Z Benet2.   

Abstract

As explained by the free drug theory, the unbound fraction of drug has long been thought to drive the efficacy of a molecule. Thus, the fraction unbound term, or fu, appears in equations for fundamental pharmacokinetic parameters such as clearance, and is used when attempting in vitro to in vivo extrapolation (IVIVE). In recent years though, it has been noted that IVIVE does not always yield accurate predictions, and that some highly protein bound ligands have more efficient uptake than can be explained by their unbound fractions. This review explores the evolution of fu terms included when implementing IVIVE, the concept of protein-facilitated uptake, and the mechanisms that have been proposed to account for facilitated uptake.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Albumin-facilitated uptake; In vitro-in vivo extrapolation; Protein binding

Mesh:

Substances:

Year:  2018        PMID: 30098391      PMCID: PMC6365006          DOI: 10.1016/j.ejps.2018.08.008

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  13 in total

Review 1.  Drug Concentration Asymmetry in Tissues and Plasma for Small Molecule-Related Therapeutic Modalities.

Authors:  Donglu Zhang; Cornelis E C A Hop; Gabriela Patilea-Vrana; Gautham Gampa; Herana Kamal Seneviratne; Jashvant D Unadkat; Jane R Kenny; Karthik Nagapudi; Li Di; Lian Zhou; Mark Zak; Matthew R Wright; Namandjé N Bumpus; Richard Zang; Xingrong Liu; Yurong Lai; S Cyrus Khojasteh
Journal:  Drug Metab Dispos       Date:  2019-07-02       Impact factor: 3.922

2.  The Presence of a Transporter-Induced Protein Binding Shift: A New Explanation for Protein-Facilitated Uptake and Improvement for In Vitro-In Vivo Extrapolation.

Authors:  Christine M Bowman; Hideaki Okochi; Leslie Z Benet
Journal:  Drug Metab Dispos       Date:  2019-01-23       Impact factor: 3.922

3.  Protein Binding and Hepatic Clearance: Re-Examining the Discrimination between Models of Hepatic Clearance with Diazepam in the Isolated Perfused Rat Liver Preparation.

Authors:  Hong-Jaan Wang; Leslie Z Benet
Journal:  Drug Metab Dispos       Date:  2019-09-28       Impact factor: 3.922

4.  Are There Any Experimental Perfusion Data that Preferentially Support the Dispersion and Parallel-Tube Models over the Well-Stirred Model of Organ Elimination?

Authors:  Jasleen K Sodhi; Hong-Jaan Wang; Leslie Z Benet
Journal:  Drug Metab Dispos       Date:  2020-04-17       Impact factor: 3.922

5.  In Vitro-In Vivo Extrapolation and Hepatic Clearance-Dependent Underprediction.

Authors:  Christine M Bowman; Leslie Z Benet
Journal:  J Pharm Sci       Date:  2019-02-25       Impact factor: 3.534

6.  Reconciling Human-Canine Differences in Oral Bioavailability: Looking beyond the Biopharmaceutics Classification System.

Authors:  Marilyn N Martinez; Ayman El-Kattan; Elias Awji; Mark Papich
Journal:  AAPS J       Date:  2019-08-08       Impact factor: 4.009

7.  Investigating the Theoretical Basis for In Vitro-In Vivo Extrapolation (IVIVE) in Predicting Drug Metabolic Clearance and Proposing Future Experimental Pathways.

Authors:  Leslie Z Benet; Jasleen K Sodhi
Journal:  AAPS J       Date:  2020-09-10       Impact factor: 4.009

8.  Challenging the Relevance of Unbound Tissue-to-Blood Partition Coefficient (Kpuu) on Prediction of Drug-Drug Interactions.

Authors:  Jasleen K Sodhi; Shuaibing Liu; Leslie Z Benet
Journal:  Pharm Res       Date:  2020-03-25       Impact factor: 4.200

Review 9.  Successful and Unsuccessful Prediction of Human Hepatic Clearance for Lead Optimization.

Authors:  Jasleen K Sodhi; Leslie Z Benet
Journal:  J Med Chem       Date:  2021-03-25       Impact factor: 7.446

Review 10.  Considerations to Be Taken When Carrying Out Medicinal Plant Research-What We Learn from an Insight into the IC50 Values, Bioavailability and Clinical Efficacy of Exemplary Anti-Inflammatory Herbal Components.

Authors:  Mona Abdel-Tawab
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.